Picture of Haw Par logo

H02 — Haw Par Share Price

0.000.00%
sg flag iconLast trade - 00:00
HealthcareConservativeMid CapNeutral

Momentum

Relative Strength (%)
1m+10.51%
3m+9.98%
6m+13.18%
1yr+5.8%
Volume Change (%)
10d/3m-45.65%
Price vs... (%)
52w High-20.22%
50d MA-2.64%
200d MA-6.17%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value0.75
Price to Tang. Book0.76
Price to Free Cashflow167.35
Price to Sales17.14
EV to EBITDA55.48

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital3.52%
Return on Equity3.61%
Operating Margin80.01%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total RevenueSG$m222.76237.81243.99111.03141.18n/an/a-6.88%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-2.36+45.75+1.63-34.28-8.12n/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for H02

Which way to trade Haw Par (SGX:H02)? background image

Which way to trade Haw Par (SGX:H02)?

As any reader of this is probably aware, shares in Haw Par (SGX:H02) are currently trading close to a 52 week high, with the share price up by around 5.71% to 13.12 over the past week. On a one-month basis, the Haw Par price has risen...

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Haw Par EPS forecast chart

Profile Summary

Haw Par Corporation Limited is a Singapore-based holding company. The principal activities of the Company are licensing of the Tiger trademarks and owning and holding investments for the long term. The Company is the owner of the Tiger trademarks. The Company's segments include Healthcare, Investments and Other. Its Healthcare division principally manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brand. Its Investment division engages in investing activities in quoted securities in Asia. Its Property division owns and leases out several investment properties in Asia. The Company's Leisure division provides family and tourist-oriented leisure activities in the form of oceanariums. Its Tiger Balm brand products include Tiger Balm White Ointment, Tiger Balm Red Ointment, Tiger Balm Ultra, Tiger Balm Soft and Tiger Balm Plaster (Warm), among others. Its Kwan Loong brand products include Kwan Loong Medicated Oil and Kwan Loong Refresher.

Directors

Last Annual
December 31st, 2021
Last Interim
December 31st, 2021
Incorporated
December 31st, 1969
Public Since
January 2nd, 1979
No. of Shareholders
19,652
No. of Employees
595
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
sg flag iconSingapore Exchange Securities Trading Ltd
Shares in Issue
221,368,173
Blurred out image of a map
Address
401 Commonwealth Drive, 149598
Web
https://www.hawpar.com/
Phone
+65 63379102
Auditors
PricewaterhouseCoopers LLP

H02 Share Price Performance

Upcoming Events for H02

Similar to H02

Picture of Hyphens Pharma International logo

Hyphens Pharma International

sg flag iconSingapore Exchange Securities Trading Ltd

Picture of IX Biopharma logo

IX Biopharma

sg flag iconSingapore Exchange Securities Trading Ltd

Picture of Pharmesis International logo

Pharmesis International

sg flag iconSingapore Exchange Securities Trading Ltd

Picture of Suntar Eco-City logo

Suntar Eco-City

sg flag iconSingapore Exchange Securities Trading Ltd

FAQ

Or unlock with your email

Or unlock with your email